[1]
|
Shin, H.R., Carlos, M.C. and Varghese, C. (2012) Cancer Control in the Asia Pacific Region: Current Status and Concerns. Japanese Journal of Clinical Oncology, 42, 867-881. http://dx.doi.org/10.1093/jjco/hys077
|
[2]
|
Mihajlovic, J., Pechlivanoglou, P., Miladinov-Mikov, M., Zivkovic, S. and Postma, M.J. (2013) Cancer Incidence and Mortality in Serbia 1999-2009. BMC Cancer, 13, 18. http://dx.doi.org/10.1186/1471-2407-13-18
|
[3]
|
Aranda-Hernández, J., Hwang, J. and Kandel, G. (2016) Seeing Better-Evidence Based Recommendations on Optimizing Colonoscopy Adenoma Detection Rate. World Journal of Gastroenterology, 22, 1767-1778.
http://dx.doi.org/10.3748/wjg.v22.i5.1767
|
[4]
|
Ballester, V., Rashtak, S. and Boardman, L. (2016) Clinical and Molecular Features of Young-Onset Colorectal Cancer. World Journal of Gastroenterology, 22, 1736-1744. http://dx.doi.org/10.3748/wjg.v22.i5.1736
|
[5]
|
Gomez, S.L., Noone, A.M., Lichtensztajn, D.Y., Scoppa, S., Gibson, J.T., Liu, L., Morris, C., Kwong, S., Fish, K., Wilkens, L.R., Goodman, M.T., Deapen, D. and Miller, B.A. (2013) Cancer Incidence Trends among Asian American Populations in the United States, 1990-2008. Journal of the National Cancer Institute, 105, 1096-1110.
http://dx.doi.org/10.1093/jnci/djt157
|
[6]
|
Wang, X., Song, Z.F., Xie, R.M., Pei, J., Xiang, M.F. and Wang, H. (2013) Analysis of Death Causes of In-Patients with Malignant Tumors in Sichuan Cancer Hospital of China from 2002 to 2012. Asian Pacific Organization for Cancer Prevention, 14, 4399-4402. http://dx.doi.org/10.7314/APJCP.2013.14.7.4399
|
[7]
|
Chen, W., Zheng, R., Zhang, S., Zhao, P., Li, G., Wu, L. and He, J. (2013) Report of Incidence and Mortality in China Cancer Registries, 2009. Chinese Journal of Cancer Research, 25, 10-21.
|
[8]
|
Li, J., Chang, J., Zhu, Y., Yang, Y., Gong, Y., Ke, J., Lou, J., Zhong, R., Gong, J., Xia, X. and Miao, X. (2015) Risk Prediction of Colorectal Cancer with Common Genetic Variants and Conventional Non-Genetic Factors in a Chinese Han population. Zhonghua Liu Xing Bing Xue Za Zhi, 36, 1053-1057.
|
[9]
|
Yao, H., Shu, C., Hu, S. and Liu, Y. (2016) Future Diagnosis and Treatment of Colorectal Cancer from the View of Precision Medicine. Zhonghua Wei Chang Wai Ke Za Zhi, 19, 7-12.
|
[10]
|
Najib, S., Kowalski-Chauvel, A., Do, C., Roche, S., Cohen-Jonathan-Moyal, E. and Seva, C. (2015) Progastrin a New Pro-Angiogenic Factor in Colorectal Cancer. Oncogene, 34, 3120-3130. http://dx.doi.org/10.1038/onc.2014.255
|
[11]
|
Paterson, A.C., Macrae, F.A., Pizzey, C., Baldwin, G.S. and Shulkes, A. (2014) Circulating Gastrin Concentrations in Patients at Increased Risk of Developing Colorectal Carcinoma. Journal of Gastroenterology and Hepatology, 29, 480-486. http://dx.doi.org/10.1111/jgh.12417
|
[12]
|
Westwood, D.A., Patel, O. and Baldwin, G.S. (2013) Gastrin Mediates Resistance to Hypoxia-Induced Cell Death in Xenografts of the Human Colorectal Cancer Cell Line LoVo. Biochimica et Biophysica Acta, 1843, 2471-2480.
http://dx.doi.org/10.1016/j.bbamcr.2014.06.016
|
[13]
|
Mao, J.D., Wu, P., Huang, J.X., Wu, J. and Yang, G. (2014) Role of ERK-MAPK Signaling Pathway in Pentagastrin-Regulated Growth of Large Intestinal Carcinoma. World Journal of Gastroenterology, 20, 12542-12550.
http://dx.doi.org/10.3748/wjg.v20.i35.12542
|
[14]
|
Chueca, E., Lanas, A. and Piazuelo, E. (2012) Role of Gastrin-Peptides in Barrett’s and Colorectal Carcinogenesis. World Journal of Gastroenterology, 18, 6560-6570. http://dx.doi.org/10.3748/wjg.v18.i45.6560
|
[15]
|
Chao, C. and Hellmich, M.R. (2010) Gastrin, Inflammation, and Carcinogenesis. Current Opinion in Endocrinology, Diabetes and Obesity, 17, 33-39.
|
[16]
|
Kreeger, P.K., Mandhana, R., Alford, S.K., Haigis, K.M. and Lauffenburger, D.A. (2009) RAS Mutations Affect Tumor Necrosis Factor-Induced Apoptosis in Colon Carcinoma Cells via ERK-Modulatory Negative and Positive Feedback Circuits along with Non-ERK Pathway Effects. Cancer Research, 69, 8191-8199.
http://dx.doi.org/10.1158/0008-5472.CAN-09-1921
|
[17]
|
Modlin, I.M., Kidd, M., Marks, I.N. and Tang, L.H. (1997) The Pivotal Role of John S. Edkins in the Discovery of Gastrin. World Journal of Surgery, 21, 226-234. http://dx.doi.org/10.1007/s002689900221
|
[18]
|
Gregory, R.A. and Tracy, H.J. (1964) The Constitution and Properties of Two Gastrins Extracted from Hog Antral Mucosa. Gut, 5, 103-114. http://dx.doi.org/10.1136/gut.5.2.103
|
[19]
|
Steigedal, T.S., Prestvik, W.S., Selvik, L.K., Fjeldbo, C.S., Bruland, T., Laegreid, A. and Thommesen, L. (2013) Gastrin-Induced Proliferation Involves MEK Partner 1 (MP1). In Vitro Cellular & Developmental Biology—Animal, 49, 162-169. http://dx.doi.org/10.1007/s11626-013-9588-2
|
[20]
|
Tripathi, S., Flobak, A., Chawla, K., Baudot, A., Bruland, T., Thommesen, L., Kuiper, M. and Laegreid, A. (2015) The Gastrin and Cholecystokinin Receptors Mediated Signaling Network: A Scaffold for Data Analysis and New Hypotheses on Regulatory Mechanisms. BMC Systems Biology, 9, 40. http://dx.doi.org/10.1186/s12918-015-0181-z
|
[21]
|
Xu, W., Chen, G.S., Shao, Y., Li, X.L., Xu, H.C., Zhang, H., Zhu, G.Q., Zhou, Y.C., He, X.P. and Sun, W.H. (2013) Gastrin Acting on the Cholecystokinin2 Receptor Induces Cyclooxygenase-2 Expression through JAK2/STAT3/PI3K/ Akt Pathway in Human Gastric Cancer Cells. Cancer Letters, 332, 11-18.
http://dx.doi.org/10.1016/j.canlet.2012.12.030
|
[22]
|
Sellam, F., Harir, N., Khaled, M.B., Mrabent, N.M., Belkralladi, H., Tou, A., Diaf, M., Salah, R. and Moulessehoul, S. (2015) Immunohistochemical Examination of Cholecystokinin and Gastrin Receptors (CCK-2/Gastrin-R) Expression in Normal and Exocrine Cancerous Human Pancreatic Tissues. Pancreatology, 15, 661-666.
http://dx.doi.org/10.1016/j.pan.2015.09.019
|
[23]
|
Hayakawa, Y., Jin, G., Wang, H., Chen, X., Westphalen, C.B., Asfaha, S., Renz, B.W., Ariyama, H., Dubeykovskaya, Z.A., Takemoto, Y., Lee, Y., Muley, A., Tailor, Y., Chen, D., Muthupalani, S., Fox, J.G., Shulkes, A., Worthley, D.L., Takaishi, S. and Wang, T.C. (2015) CCK2R Identifies and Regulates Gastric Antral Stem Cell States and Carcinogenesis. Gut, 64, 544-553. http://dx.doi.org/10.1136/gutjnl-2014-307190
|
[24]
|
Cui, Y., Li, S.B., Peng, X.C., Wu, J. and Fu, G.H. (2015) Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells through Gastrin-Initialized CCKBR Signaling. Digestive Diseases and Sciences, 60, 3631-3641.
http://dx.doi.org/10.1007/s10620-015-3793-7
|
[25]
|
Patel, M., Kawano, T., Suzuki, N., Hamakubo, T., Karginov, A.V. and Kozasa, T. (2014) Gα13/PDZ-RhoGEF/RhoA Signaling Is Essential for Gastrin-Releasing Peptide Receptor-Mediated Colon Cancer Cell Migration. Molecular Pharmacology, 86, 252-262. http://dx.doi.org/10.1124/mol.114.093914
|
[26]
|
Song, Y., Xu, Y., Wang, Z., Chen, Y., Yue, Z., Gao, P., Xing, C. and Xu, H. (2012) MicroRNA-148b Suppresses Cell Growth by Targeting Cholecystokinin-2 Receptor in Colorectal Cancer. International Journal of Cancer, 131, 1042-1051. http://dx.doi.org/10.1002/ijc.26485
|
[27]
|
Jin, G., Westphalen, C.B., Hayakawa, Y., Worthley, D.L., Asfaha, S., Yang, X., Chen, X., Si, Y., Wang, H., Tailor, Y., Friedman, R.A. and Wang, T.C. (2013) Progastrin Stimulates Colonic Cell Proliferation via CCK2R- and β-Arrestin-Dependent Suppression of BMP2. Gastroenterology, 145, 820-830. http://dx.doi.org/10.1053/j.gastro.2013.07.034
|
[28]
|
Wu, P., Mao, J.D., Yan, J.Y., Rui, J., Zhao, Y.C., Li, X.H. and Xu, G.Q. (2005) Correlation between the Expressions of Gastrin, Somatostatin and Cyclin and Cyclin-Depend Kinase in Colorectal Cancer. World Journal of Gastroenterology, 11, 7211-7217. http://dx.doi.org/10.3748/wjg.v11.i45.7211
|
[29]
|
Huang, B.P., Lin, C.H., Chen, Y.C. and Kao, S.H. (2015) Expression of Cholecystokinin Receptors in Colon Cancer and the Clinical Correlation in Taiwan. Tumor Biology, 37, 4579-4584. http://dx.doi.org/10.1007/s13277-015-4306-1
|
[30]
|
Mao, J.D., Wu, P., Yang, Y.L., Wu, J. and Huang, H. (2008) Relationship between Expression of Gastrin, Somatostatin, Fas/FasL and Caspases in Large Intestinal Carcinoma. World Journal of Gastroenterology, 14, 2802-2809.
http://dx.doi.org/10.3748/wjg.14.2802
|
[31]
|
Han, Y.M., Park, J.M., Kangwan, N., Jeong, M., Lee, S., Cho, J.Y., Ko, W.J. and Hahm, K.B. (2015) Role of Proton Pump Inhibitors in Preventing Hypergastrinemia-Associated Carcinogenesis and in Antagonizing the Trophic Effect of Gastrin. Journal of Physiology and Pharmacology, 66, 159-167.
|
[32]
|
Mao, J.D., Wu, P., Xia, X.H., Hu, J.Q., Huang, W.B. and Xu, G.Q. (2005) Correlation between Expression of Gastrin, Somatostatin and Cell Apoptosis Regulation Gene Bcl-2/Bax in Large Intestine Carcinoma. World Journal of Gastroenterology, 11, 721-725. http://dx.doi.org/10.3748/wjg.v11.i5.721
|
[33]
|
Wu, P., Mao, J.D., Zhao, Y.C., Wu, J. and Huang, H. (2010) Relationship between the Cells Proliferation of Large Intestinal Cancer Induced by Gastrin and Signaling Transduction Pathway of STAT3. International Journal of Surgery, 37, 243-247.
|
[34]
|
Zalata, K.R., Elshal, M.F., Foda, A.A. and Shoma, A. (2015) Genetic Dissimilarity between Primary Colorectal Carcinomas and Their Lymph Node Metastases: Ploidy, p53, Bcl-2, and c-Myc Expression—A Pilot Study. Tumor Biology, 36, 6579-6584. http://dx.doi.org/10.1007/s13277-015-3353-y
|
[35]
|
Mansour, M.A., Hyodo, T., Ito, S., Kurita, K., Kokuryo, T., Uehara, K., Nagino, M., Takahashi, M., Hamaguchi, M. and Senga, T. (2015) SATB2 Suppresses the Progression of Colorectal Cancer Cells via Inactivation of MEK5/ERK5 Signaling. The FEBS Journal, 282, 1394-1405. http://dx.doi.org/10.1111/febs.13227
|
[36]
|
Wang, B., Shen, Z.L., Gao, Z.D., Zhao, G., Wang, C.Y., Yang, Y., Zhang, J.Z., Yan, Y.C., Shen, C., Jiang, K.W., Ye, Y.J. and Wang, S. (2015) MiR-194, Commonly Repressed in Colorectal Cancer, Suppresses Tumor Growth by Regulating the MAP4K4/c-Jun/MDM2 Signaling Pathway. Cell Cycle, 14, 1046-1058.
http://dx.doi.org/10.1080/15384101.2015.1007767
|
[37]
|
Huseby, N.E., Ravuri, C. and Moens, U. (2016) The Proteasome Inhibitor Lactacystin Enhances GSH Synthesis Capacity by Increased Expression of Antioxidant Components in an Nrf2-Independent, but p38 MAPK-Dependent Manner in Rat Colorectal Carcinoma Cells. Free Radical Research, 50, 1-13.
http://dx.doi.org/10.3109/10715762.2015.1100730
|
[38]
|
Xiang, T., Fei, R., Wang, Z., Shen, Z., Qian, J. and Chen, W. (2016) Nicotine Enhances Invasion and Metastasis of Human Colorectal Cancer Cells through the Nicotinic Acetylcholine Receptor Downstream p38 MAPK Signaling Pathway. Oncology Reports, 35, 205-210.
|
[39]
|
Del Reino, P., Alsina-Beauchamp, D., Escós, A., Cerezo-Guisado, M.I., Risco, A., Aparicio, N., Zur, R., Fernandez-Estévez, M., Collantes, E., Montans, J. and Cuenda, A. (2014) Pro-Oncogenic Role of Alternative p38 Mitogen-Activated Protein Kinases p38γ and p38δ, Linking Inflammation and Cancer in Colitis-Associated Colon Cancer. Cancer Research, 74, 6150-6160. http://dx.doi.org/10.1158/0008-5472.CAN-14-0870
|
[40]
|
Ramachandra, C.J., Mehta, A., Wong, P. and Shim, W. (2016) ErbB4 Activated p38γ MAPK Isoform Mediates Early Cardiogenesis through NKx2.5 in Human Pluripotent Stem Cells. Stem Cells, 34, 288-298.
http://dx.doi.org/10.1002/stem.2223
|
[41]
|
Wang, J., Huang, F., Bai, Z., Chi, B., Wu, J. and Chen, X. (2015) Curcumol Inhibits Growth and Induces Apoptosis of Colorectal Cancer LoVo Cell Line via IGF-1R and p38 MAPK Pathway. International Journal of Molecular Sciences, 16, 19851-19867. http://dx.doi.org/10.3390/ijms160819851
|
[42]
|
Song, H.M., Park, G.H., Eo, H.J., Lee, J.W., Kim, M.K., Lee, J.R., Lee, M.H., Koo, J.S. and Jeong, J.B. (2015) Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells. Biomolecules & Therapeutics (Seoul), 23, 339-344. http://dx.doi.org/10.4062/biomolther.2015.024
|
[43]
|
Ren, H., Zhang, S., Ma, H., Wang, Y., Liu, D., Wang, X. and Wang, Z. (2014) Matrine Reduces the Proliferation and Invasion of Colorectal Cancer Cells via Reducing the Activity of p38 Signaling Pathway. Acta Biochimica et Biophysica Sinica, 46, 1049-1055. http://dx.doi.org/10.1093/abbs/gmu101
|
[44]
|
Ming, M., Yu, J.P., Zhou, Y.H., Cao, J., Song, W.C., Yu, H.G. and Luo, H.S. (2007) The Role of p38 MAPK in Gastrin-Induced U-PA Expression in Human Colon Cancer Cells. Chinese Journal of Oncology, 29, 4-8.
|
[45]
|
Han, Y.M., Hahm, K.B., Park, J.M., Hong, S.P. and Kim, E.H. (2013) Paradoxically Augmented Anti-Tumorigenic Action of Proton Pump Inhibitor and Gastrinin APCMin/+ Intestinal Polyposis Model1. Neoplasia, 16, 73-83.
http://dx.doi.org/10.1593/neo.131510
|